46-60 of 778
Advancements in gMG Management: Zilucoplan as an Alternative to C5 Inhibitors
NeuroFrontiersAdvancements in gMG Management: Zilucoplan as an Alternative to C5 Inhibitors
Examining Inebilizumab in Generalized Myasthenia Gravis: Insights from MINT
NeuroFrontiersExamining Inebilizumab in Generalized Myasthenia Gravis: Insights from MINT
Advancing MS Care: Diagnostic Clarity, Early Action, and Patient-Centered Treatment
On the Frontlines of Multiple SclerosisAdvancing MS Care: Diagnostic Clarity, Early Action, and Patient-Centered Treatment
Prevention on the Horizon: Early Intervention and Risk Reduction in MS Care
On the Frontlines of Multiple SclerosisPrevention on the Horizon: Early Intervention and Risk Reduction in MS Care
Evolving Diagnostic and Prognostic Strategies in Multiple Sclerosis Care
On the Frontlines of Multiple SclerosisEvolving Diagnostic and Prognostic Strategies in Multiple Sclerosis Care
Genetic Testing in Pediatrics: Identifying Neurodevelopmental Disorders Early
Clinician's RoundtableGenetic Testing in Pediatrics: Identifying Neurodevelopmental Disorders Early
- advertisement
Genetic Pathways in MS: The Clinical Impact of a Chromosome 2 Variant
NeuroFrontiersGenetic Pathways in MS: The Clinical Impact of a Chromosome 2 Variant
Understanding Antibody-Mediated Demyelinating Diseases: Key Differences From MS
NeuroFrontiersUnderstanding Antibody-Mediated Demyelinating Diseases: Key Differences From MS
Navigating MS Diagnosis in Older Adults: Distinguishing Comorbidities and Mimics
NeuroFrontiersNavigating MS Diagnosis in Older Adults: Distinguishing Comorbidities and Mimics
Retinal Vein Occlusion as a Predictor of Stroke
Eye on Ocular HealthRetinal Vein Occlusion as a Predictor of Stroke
Valbenazine and Patient-Centered Outcomes in TD: Insights From the KINECT-PRO Study
Psychiatry and Mental HealthValbenazine and Patient-Centered Outcomes in TD: Insights From the KINECT-PRO Study
Valbenazine for TD: Consistent Long-Term Efficacy Across Racial and Ethnic Subgroups in KINECT-4
Psychiatry and Mental HealthValbenazine for TD: Consistent Long-Term Efficacy Across Racial and Ethnic Subgroups in KINECT-4
- advertisement
Decoding Disability Worsening in MS: The Case for Combining CSF and Serum Biomarkers
NeuroFrontiersDecoding Disability Worsening in MS: The Case for Combining CSF and Serum Biomarkers
Timing Matters: Influenza Vaccination Response in MS Patients on Ofatumumab
NeuroFrontiersTiming Matters: Influenza Vaccination Response in MS Patients on Ofatumumab
Modern MS Management: Leveraging Technology to Support Brain Health
On the Frontlines of Multiple SclerosisModern MS Management: Leveraging Technology to Support Brain Health
